Jabodon PT Co’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Jabodon PT Co’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-147,879	Closed	-$10.8M	–	33
2020 Q4	$10.8M	Buy	+147,879	New	+$11M	6.58%	7
2020 Q3	–	Sell	-80,681	Closed	-$4.48M	–	58
2020 Q2	$4.48M	Sell	80,681 -59,847	-43%	-$2.56M	1.27%	4
2020 Q1	$4.16M	Buy	140,528 +43,505	+45%	+$1.47M	1.19%	7
2019 Q4	$3.51M	Sell	97,023 -48,862	-33%	-$1.5M	1.34%	13
2019 Q3	$3.97M	Sell	145,885 -41,923	-22%	-$1.08M	1.67%	12
2019 Q2	$4.52M	Buy	187,808 +73,121	+64%	+$1.85M	3.52%	7
2019 Q1	$3.03M	Buy	114,687 +895	+0.8%	+$21.2K	2.55%	9
2018 Q4	$2.22M	Sell	113,792 -7,366	-6%	-$144K	2.05%	7
2018 Q3	$2.37M	Buy	+121,158	New	+$2.3M	3.09%	12
2018 Q2	–	Sell	-152,676	Closed	-$2.17M	–	21
2018 Q1	$2.17M	Buy	+152,676	New	+$2.26M	1.96%	15

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Jabodon PT Co's HZNP Position: Q1 2021 in Review

Jabodon PT Co sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2021, closing a stake of 147,879 shares — an estimated $10.8M sold.

Jabodon PT Co first reported a position in HZNP in Q1 2018 and held it in 10 quarters. The position peaked at $10.8M in Q4 2020. 516 funds tracked by Wall St. Rank hold HZNP as of Q1 2021.

Jabodon PT Co reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2021 after selling out during the quarter.
Jabodon PT Co sold 147,879 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2021, an estimated $10.8M.
Jabodon PT Co first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2018 and held it in 10 quarters.
Jabodon PT Co's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $10.8M in Q4 2020.
516 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2021.

Based on Jabodon PT Co's 13F filing for Q1 2021, filed 11 May 2021.